menu
{ "item_title" : "Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers", "item_author" : [" Andrea Necchi", "Philippe E. Spiess "], "item_description" : "Introduction.- State-of-the art and ongoing developments.- Clinical cases debate: neoadjuvant checkpoint inhibition vs standard chemotherapy.- Slideshow of tumor samples before and after checkpoint inhibition.- Ongoing trials and clinical trials endpoints debate: the role of pathological response as a surrogate of survival endpoints.- State-of-the-art and future role of molecular biomarkers for patient selection.- Background of immunotherapy trials in prostate cancer.- Clinical case debate: immunotherapy vs alternative therapies in the neoadjuvant and adjuvant setting of localized, high-risk prostate cancer.- Cytoreductive nephrectomy in the era of targeted therapy and immunotherapy.- Clinical cases debate: Neoadjuvant vs adjuvant immunotherapy in localized RCC.- Benchmark of surgical safety results.- What the scientific data tell us about predictive biomarkers of immunotherapy efficacy across the GU malignancies.- Clinical cases debate: biomarker-driven patient selection vs unselective perioperative strategies.", "item_img_path" : "https://covers4.booksamillion.com/covers/bam/3/03/080/548/3030805484_b.jpg", "price_data" : { "retail_price" : "119.99", "online_price" : "119.99", "our_price" : "119.99", "club_price" : "119.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers|Andrea Necchi

Neoadjuvant Immunotherapy Treatment of Localized Genitourinary Cancers : Multidisciplinary Management

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

Introduction.- State-of-the art and ongoing developments.- Clinical cases debate: neoadjuvant checkpoint inhibition vs standard chemotherapy.- Slideshow of tumor samples before and after checkpoint inhibition.- Ongoing trials and clinical trials endpoints debate: the role of pathological response as a surrogate of survival endpoints.- State-of-the-art and future role of molecular biomarkers for patient selection.- Background of immunotherapy trials in prostate cancer.- Clinical case debate: immunotherapy vs alternative therapies in the neoadjuvant and adjuvant setting of localized, high-risk prostate cancer.- Cytoreductive nephrectomy in the era of targeted therapy and immunotherapy.- Clinical cases debate: Neoadjuvant vs adjuvant immunotherapy in localized RCC.- Benchmark of surgical safety results.- What the scientific data tell us about predictive biomarkers of immunotherapy efficacy across the GU malignancies.- Clinical cases debate: biomarker-driven patient selection vs unselective perioperative strategies.

This item is Non-Returnable

Details

  • ISBN-13: 9783030805487
  • ISBN-10: 3030805484
  • Publisher: Springer
  • Publish Date: January 2023
  • Dimensions: 9.21 x 6.14 x 0.7 inches
  • Shipping Weight: 1.04 pounds
  • Page Count: 315

Related Categories

You May Also Like...

    1

BAM Customer Reviews